Double maintains 4 strategies that include HRMY - Harmony Biosciences Holdings, Inc.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RDDT | -18.12% | $29.40B | +116.44% | 0.00% |
| OMCL | -17.00% | $1.40B | +11.36% | 0.00% |
| JBI | -11.45% | $1.26B | -28.39% | 0.00% |
| GRMN | -11.22% | $41.09B | +32.42% | 1.47% |
| K | -10.79% | $27.76B | +41.17% | 2.85% |
| LNTH | -9.71% | $5.51B | +0.08% | 0.00% |
| PRPO | -9.42% | $17.08M | +125.94% | 0.00% |
| UUU | -8.39% | $7.17M | +101.30% | 0.00% |
| VSA | -7.81% | $8.67M | -19.04% | 0.00% |
| EXEL | -7.56% | $12.08B | +101.73% | 0.00% |
| NEUE | -7.19% | $61.24M | +29.92% | 0.00% |
| DFDV | -6.99% | $300.56M | +2,130.16% | 0.00% |
| MVO | -6.54% | $66.47M | -37.17% | 21.45% |
| HUSA | -5.01% | $19.66M | -19.53% | 0.00% |
| HLIT | -4.86% | $1.10B | -18.24% | 0.00% |
| HURN | -4.62% | $2.39B | +41.66% | 0.00% |
| PEN | -4.52% | $9.67B | +40.76% | 0.00% |
| TMDX | -4.37% | $4.32B | -14.61% | 0.00% |
| IEP | -3.97% | $4.66B | -48.88% | 29.28% |
| SMP | -3.36% | $731.97M | +23.38% | 3.61% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XPH | 38.33% | $147.96M | 0.35% |
| SMMV | 35.73% | $317.06M | 0.2% |
| FV | 35.43% | $3.66B | 0.87% |
| PBE | 35.06% | $223.19M | 0.58% |
| DSTL | 34.98% | $1.79B | 0.39% |
| FLQM | 34.62% | $1.67B | 0.3% |
| RZV | 34.19% | $203.10M | 0.35% |
| JQUA | 34.17% | $6.38B | 0.12% |
| RUNN | 34.15% | $366.41M | 0.58% |
| SMOT | 34.15% | $387.12M | 0.49% |
| MOAT | 34.01% | $12.66B | 0.47% |
| SPHQ | 34.01% | $14.10B | 0.15% |
| SLYV | 33.94% | $3.64B | 0.15% |
| VIOV | 33.93% | $1.27B | 0.1% |
| USMF | 33.93% | $408.48M | 0.28% |
| XT | 33.88% | $3.40B | 0.46% |
| XSLV | 33.82% | $276.65M | 0.25% |
| FXH | 33.81% | $903.07M | 0.62% |
| RSP | 33.77% | $72.80B | 0.2% |
| NULV | 33.75% | $1.73B | 0.26% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IBTI | -0.03% | $1.06B | 0.07% |
| AGZ | 0.14% | $614.58M | 0.2% |
| BILZ | -0.20% | $821.74M | 0.14% |
| TBLL | 0.20% | $2.13B | 0.08% |
| BIL | -0.37% | $42.24B | 0.1356% |
| SHV | -0.37% | $20.64B | 0.15% |
| IBTG | -0.38% | $1.92B | 0.07% |
| AGGH | -0.48% | $324.95M | 0.29% |
| UDN | -0.49% | $148.33M | 0.78% |
| VGSH | -0.49% | $22.80B | 0.03% |
| FXE | 0.51% | $568.94M | 0.4% |
| GBIL | 0.57% | $6.37B | 0.12% |
| SHYM | 0.72% | $357.13M | 0.35% |
| TFLO | -0.72% | $6.82B | 0.15% |
| XBIL | 0.73% | $783.90M | 0.15% |
| UUP | -0.86% | $201.63M | 0.77% |
| PWZ | 0.90% | $759.91M | 0.28% |
| STXT | 0.94% | $129.40M | 0.49% |
| IBTK | 1.01% | $448.89M | 0.07% |
| XHLF | -1.02% | $1.73B | 0.03% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -29.16% | $164.54M | 0.85% |
| TAIL | -26.51% | $99.63M | 0.59% |
| BTAL | -12.48% | $296.22M | 1.43% |
| ULST | -9.99% | $654.75M | 0.2% |
| CMBS | -9.62% | $449.66M | 0.25% |
| XONE | -8.11% | $625.28M | 0.03% |
| DBE | -7.98% | $52.20M | 0.77% |
| UGA | -6.85% | $72.33M | 0.97% |
| IBTF | -6.81% | $1.99B | 0.07% |
| USL | -6.16% | $42.23M | 0.85% |
| BNO | -5.94% | $103.79M | 1% |
| FXY | -5.49% | $816.38M | 0.4% |
| USO | -5.09% | $1.13B | 0.6% |
| TPMN | -5.02% | $30.70M | 0.65% |
| OILK | -4.52% | $71.87M | 0.69% |
| STPZ | -4.42% | $450.47M | 0.2% |
| CGSM | -4.37% | $709.45M | 0.25% |
| LDUR | -4.36% | $929.65M | 0.5% |
| BSMW | -4.25% | $107.45M | 0.18% |
| IVOL | -4.06% | $347.03M | 1.02% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CLLS | -<0.01% | $118.95M | -19.51% | 0.00% |
| TAC | 0.25% | $3.15B | +53.17% | 1.65% |
| TZOO | 0.28% | $146.68M | +75.10% | 0.00% |
| VSTA | 0.31% | $344.07M | +39.29% | 0.00% |
| MO | -0.32% | $99.67B | +28.77% | 6.90% |
| XBIO | -0.41% | $6.08M | +5.25% | 0.00% |
| CPSH | 0.41% | $42.27M | +74.25% | 0.00% |
| COMP | 0.44% | $3.36B | +80.34% | 0.00% |
| SRE | 0.50% | $48.80B | -0.47% | 3.37% |
| XOS | 0.53% | $26.93M | -52.42% | 0.00% |
| PRMB | -0.70% | $11.33B | +47.96% | 1.26% |
| BTCT | -0.77% | $25.56M | +61.14% | 0.00% |
| SYPR | 0.86% | $48.49M | +14.05% | 0.00% |
| CECO | 0.94% | $1.03B | +2.72% | 0.00% |
| HIHO | 0.94% | $7.22M | -20.82% | 4.49% |
| DQ | -1.02% | $1.18B | +11.88% | 0.00% |
| PPC | -1.06% | $10.84B | +33.46% | 0.00% |
| GHI | -1.11% | $272.81M | -20.46% | 12.24% |
| ETR | 1.22% | $35.03B | +54.09% | 4.33% |
| LRN | 1.23% | $5.99B | +100.06% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ESAB | 42.82% | $7.57B | +34.01% | 0.19% |
| AVNS | 41.84% | $572.50M | -36.25% | 0.00% |
| WING | 41.81% | $9.10B | -22.03% | 0.33% |
| OPCH | 41.39% | $5.08B | +15.10% | 0.00% |
| CLH | 41.34% | $12.34B | +2.69% | 0.00% |
| BLKB | 41.24% | $3.15B | -14.51% | 0.00% |
| QRVO | 40.31% | $8.20B | -24.63% | 0.00% |
| GIC | 40.06% | $1.08B | -9.65% | 3.61% |
| GPRO | 38.84% | $116.59M | -47.14% | 0.00% |
| ATNI | 38.41% | $261.42M | -23.13% | 5.78% |
| CDW | 37.94% | $24.08B | -16.17% | 1.36% |
| AVNT | 37.64% | $3.15B | -19.18% | 3.10% |
| THRY | 37.63% | $549.35M | -28.31% | 0.00% |
| SIBN | 37.05% | $785.39M | +41.33% | 0.00% |
| SAGE | 36.40% | $568.61M | -14.50% | 0.00% |
| VRNS | 36.36% | $5.60B | +4.27% | 0.00% |
| NOVT | 36.07% | $4.78B | -17.12% | 0.00% |
| FLYW | 35.97% | $1.44B | -25.92% | 0.00% |
| SYNA | 35.06% | $2.63B | -22.41% | 0.00% |
| DCI | 34.54% | $8.29B | +0.07% | 1.56% |
Current Value
$32.301 Year Return
Current Value
$32.301 Year Return
Yahoo
HRMY isn't your typical cannabis play - its synthetic CBD gel targets rare brain disorders with no approved therapies.
Yahoo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the 13 Small Cap Stocks Analysts Are Bullish On. Needham analyst Ami Fadia maintained a Buy rating on Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) on June 6 and set a price target of $49.00. The analyst based the rating on the company’s promising developments and data, citing the […]
SeekingAlpha
This is our monthly dashboard series on Healthcare and Pharma stocks. Read the full analysis here, and which 10 healthcare stocks were cheaper than their peers in June 2025.
Yahoo
PLYMOUTH MEETING, Pa., June 11, 2025--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the presentation of preclinical pharmacological effect data for BP1.15205, an investigational, highly potent, and potentially best-in-class orexin 2 receptor (OX2R) agonist, which demonstrated significant wake-promoting and cataplexy-suppressing effects in a standard transgenic mouse model of narcolepsy type 1. The data will be presented at the 39th Annual Meeting of the Associated Professiona
Finnhub
Presenter SpeechUnknown Analyst Everyone, and welcome to the Goldman Sachs Healthcare Conference. Thanks so much to the team from Harmony Biosciences for just joining us here today. And yes, I
Yahoo
We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Capital Curiosity’s Substack by Taylor Nichols. In this article, we will summarize the bulls’ thesis on HRMY. Harmony Biosciences Holdings, Inc. (HRMY)’s share was trading at $35.03 as of 5th June. HRMY’s trailing and forward P/E were 13.37 and 9.45 respectively according to Yahoo […]
